The biopharma Terns Pharmaceuticals (NSDQ:TERN) has appointed Dr. ​​Ann E. Taylor to its board of directors.  Taylor, who served as AstraZeneca‘s chief medical officer from April 2019 to August 2021, has more than 35 years of experience in drug development. Other notable companies she has worked for include Pfizer, Novartis and AstraZeneca subsidiary MedImmune.  Dr.…